Company
Provention Bio
Claim, correct or request removal
Record updated 28 September 2026
About
Building and advancing a diversified portfolio of advanced clinical-stage and pre commercial-stage candidates that intercept, prevent or delay the progression of debilitating, life-impacting, and life-threatening diseases such as type 1 diabetes, celiac disease, and lupus (NASDAQ: PRVB)
Loading relationship preview